107 related articles for article (PubMed ID: 11682807)
1. Hospitals boost performance with beta blocker data.
Data Strateg Benchmarks; 2001 Oct; 5(10):149-51, 145. PubMed ID: 11682807
[TBL] [Abstract][Full Text] [Related]
2. Hospitals boost performance with beta blocker data.
Clin Resour Manag; 2002 Apr; 3(4):58-60. PubMed ID: 11974637
[No Abstract] [Full Text] [Related]
3. Study outlines key factors in successful beta-blocker use.
Rollins G
Rep Med Guidel Outcomes Res; 2001 Jun; 12(13):1-2, 5. PubMed ID: 12182170
[No Abstract] [Full Text] [Related]
4. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM
Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
[TBL] [Abstract][Full Text] [Related]
5. Physician prescribing and the hippocratic oath.
Mullins CD
Clin Ther; 2005 May; 27(5):628-9. PubMed ID: 15978312
[No Abstract] [Full Text] [Related]
6. A slow trickledown. Data on efficacy of beta blockers belatedly spur use.
Moore JD
Mod Healthc; 1998 Sep; 28(37):70. PubMed ID: 10183097
[No Abstract] [Full Text] [Related]
7. Optimizing beta-blocker use after myocardial infarction.
Howard PA; Ellerbeck EF
Am Fam Physician; 2000 Oct; 62(8):1853-60, 1865-6. PubMed ID: 11057841
[TBL] [Abstract][Full Text] [Related]
8. Practice patterns in hypertension.
Hardin B
CMAJ; 1997 Nov; 157(10):1348-9. PubMed ID: 9371060
[No Abstract] [Full Text] [Related]
9. Lack of physician concordance with guidelines on the perioperative use of beta-blockers.
Siddiqui AK; Ahmed S; Delbeau H; Conner D; Mattana J
Arch Intern Med; 2004 Mar; 164(6):664-7. PubMed ID: 15037496
[TBL] [Abstract][Full Text] [Related]
10. Between-country variation in the utilization of antihypertensive agents: Guidelines and clinical practice.
Stolk P; Van Wijk BL; Leufkens HG; Heerdink ER
J Hum Hypertens; 2006 Dec; 20(12):917-22. PubMed ID: 16988753
[TBL] [Abstract][Full Text] [Related]
11. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
[TBL] [Abstract][Full Text] [Related]
12. Why aren't we using beta blockers after acute MI?
Weichel AS
Am Fam Physician; 2000 Oct; 62(8):1771-2. PubMed ID: 11057834
[No Abstract] [Full Text] [Related]
13. Measurement of changes in antihypertensive drug utilisation following primary care educational interventions.
Horn FE; Mandryk JA; Mackson JM; Wutzke SE; Weekes LM; Hyndman RJ
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):297-308. PubMed ID: 16634120
[TBL] [Abstract][Full Text] [Related]
14. Beta blocker use in acute myocardial infarction in West Virginia.
Schade CP; Brehm JG; Stephens MK; Rezek G
W V Med J; 2002; 98(2):56-60. PubMed ID: 12048739
[TBL] [Abstract][Full Text] [Related]
15. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
[TBL] [Abstract][Full Text] [Related]
16. Changes in the usage of antihypertensive drugs: implications and prospects.
Schachter M
Br J Clin Pharmacol; 2005 Sep; 60(3):231-4. PubMed ID: 16120060
[No Abstract] [Full Text] [Related]
17. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.
Ansari M; Shlipak MG; Heidenreich PA; Van Ostaeyen D; Pohl EC; Browner WS; Massie BM
Circulation; 2003 Jun; 107(22):2799-804. PubMed ID: 12756157
[TBL] [Abstract][Full Text] [Related]
18. Are beta-blockers really underutilized in postinfarction patients?
O'Rourke RA
J Am Coll Cardiol; 1995 Nov; 26(6):1437-9. PubMed ID: 7594067
[No Abstract] [Full Text] [Related]
19. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
Al Khaja KA; Sequeira RP
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
[TBL] [Abstract][Full Text] [Related]
20. The roles of senior management in quality improvement efforts: what are the key components?
Bradley EH; Holmboe ES; Mattera JA; Roumanis SA; Radford MJ; Krumholz HM
J Healthc Manag; 2003; 48(1):15-28; discussion 29. PubMed ID: 12592866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
